









Markets
/
Stocks
/
nasdaq-wgrx
/

WGRX

0.312USD

-0.007-2.10%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

27.89MMarket Cap

LossP/E TTM



WGRX

0.312

-0.007-2.10%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of WGRX

Currency: USD Updated: 2026-02-06

Key Insights

Wellgistics Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 148 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

WGRX's Score

Industry at a Glance

Industry Ranking

148 / 205

Overall Ranking

491 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

WGRX Highlights

StrengthsRisks

Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.

Growing

The company is in a growing phase, with the latest annual income totaling USD 18.13M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 18.13M.

Overvalued

The company’s latest PE is -0.25, at a high 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 851.12K shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Wellgistics Health Inc is 5.49, ranking 197 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 3.01M, representing a year-over-year decrease of 46.90%, while its net profit experienced a year-over-year decrease of 1738.12%.

Score

Industry at a Glance

Previous score

5.49

Change



Financials

4.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.94

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

3.27

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

WGRX's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Wellgistics Health Inc is 7.23, ranking 109 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.25, which is -100.00% below the recent high of 0.00 and -2367.52% above the recent low of -6.05.

Score

Industry at a Glance

Previous score

7.23

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 148/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Wellgistics Health Inc. The Healthcare Equipment & Supplies industry's average is 7.77.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Wellgistics Health Inc is 5.18, ranking 183 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.41 and the support level at 0.26, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.93

Change

0.25

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.005

Sell

RSI(14)

34.066

Neutral

STOCH(KDJ)(9,3,3)

11.367

Oversold

ATR(14)

0.030

High Vlolatility

CCI(14)

-113.692

Sell

Williams %R

90.545

Oversold

TRIX(12,20)

-1.095

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.332

Sell

MA10

0.351

Sell

MA20

0.379

Sell

MA50

0.456

Sell

MA100

0.596

Sell

MA200

1.139

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Norton (Brian)

18.20M

Gundlapalli (Annapurna)

8.94M

Patel Prashant

6.52M

Ajjarapu (Surendra K)

5.98M

Patel Trust 2010

4.47M

Ajjarapu (Sandhya)

4.46M

Heights Capital Management, Inc.

2.92M

The Vanguard Group, Inc.

Star Investors

739.24K

Canning (Tim)

750.00K

Kalla (Srinivas)

293.33K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Wellgistics Health Inc is 1.11, ranking 201 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.